Evidence map›Paper›PMID 27067350›Full record

ArticleJournal of general internal medicine2016

Financial Incentives and Diabetes Disease Control in Employees: A Retrospective Cohort Analysis.

Anita D Misra-Hebert, Bo Hu, Glen Taksler, Robert Zimmerman, Michael B Rothberg

Open access · bronzeAbstract read
In one paragraph

Article in Journal of general internal medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Financial incentives in the management of diabetes: a systematic review.Cost effectiveness and resource allocation : C/E · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Anita D Misra-HebertCenter for Value-Based Care Research, Medicine Institute, Cleveland Clinic, Cleveland, OH, USA. misraa@ccf.org.
Bo HuDepartment of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
Glen TakslerCenter for Value-Based Care Research, Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
Robert ZimmermanDiabetes Center, Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, OH, USA.
Michael B RothbergCenter for Value-Based Care Research, Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
Cleveland Clinic · US

Funding

Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Clinical and Translational Science Collaborative of ClevelandKL2TR000440 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$11.1M
NCATS NIH HHS KL2 TR000440NCATS NIH HHS UL1 TR000439
6 · The paper itself

Abstract

backgroundMany employers offer worksite wellness programs, including financial incentives to achieve goals. Evidence supporting such programs is sparse.

objectiveTo assess whether diabetes and cardiovascular risk factor control in employees improved with financial incentives for participation in disease management and for attaining goals.

designRetrospective cohort study using insurance claims linked with electronic medical record data from January 2008-December 2012.

participantsEmployee patients with diabetes covered by the organization's self-funded insurance and propensity-matched non-employee patient comparison group with diabetes and commercial insurance.

interventionFinancial incentives for employer-sponsored disease management program participation and achieving goals. MAIN MEASURES: Change in glycosylated hemoglobin (HbA1c), low-density lipoprotein (LDL), systolic blood pressure (SBP), and weight.

resultsA total of 1092 employees with diabetes were matched to non-employee patients. With increasing incentives, employee program participation increased (7 % in 2009 to 50 % in 2012, p < 0.001). Longitudinal mixed modeling demonstrated improved diabetes and cardiovascular risk factor control in employees vs. non-employees [HbA1c yearly change -0.05 employees vs. 0.00 non-employees, difference in change (DIC) p <0.001]. In their first participation year, employees had larger declines in HbA1c and weight vs. non-employees (0.33 vs. 0.14, DIC p = 0.04) and (2.3 kg vs. 0.1 kg, DIC p < 0.001), respectively. Analysis of employee cohorts corresponding with incentive offerings showed that fixed incentives (years 1 and 2) or incentives tied to goals (years 3 and 4) were not significantly associated with HbA1c reductions compared to non-employees. For each employee cohort offered incentives, SBP and LDL also did not significantly differ in employees compared with non-employees (DIC p > 0.05).

conclusionsFinancial incentives were associated with employee participation in disease management and improved cardiovascular risk factors over 5 years. Improvements occurred primarily in the first year of participation. The relative impact of specific incentives could not be discerned.

Indexed as

Disease ManagementMotivationAdultCohort StudiesDiabetes MellitusFemaleHealth PromotionHumansLongitudinal StudiesMaleMiddle AgedOccupational Health ServicesRetrospective StudiesWorkplacechronic diseasediabetesdisease managementhealth promotion

Identifiers

PMID27067350
PMCPMC4945561
OpenAlexW2338805408

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.